Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
Technology in Cancer Research & Treatment|January 8, 2026
Historic Real-World Outcomes and Future Benchmarks for Patients with Diffuse Large B-Cell Lymphoma Receiving First- and Second-Line Therapy in Austria - a Large Single-Center ExperienceMichael Leisch, Dominik Kiem, Christoph Grabmer, et al.
Plos One|July 8, 2017
Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapyTeresa Magnes, Thomas Melchardt, Lukas Weiss, et al.
Annals of Hematology|November 13, 2014
Non-pegylated liposomal doxorubicin in lymphoma: patterns of toxicity and outcome in a large observational trialInes Wasle, Gabriele Gamerith, Florian Kocher, et al.
Hematological Oncology|August 7, 2020
A phase 1 study to evaluate the feasibility and efficacy of the addition of ropeginterferon alpha-2b to imatinib treatment in patients with chronic phase chronic myeloid leukemia (CML) not achieving a deep molecular response (molecular remission 4.5)-AGMT_CML 1Sonja Heibl, Veronika Buxhofer-Ausch, Stefan Schmidt, et al.
Haematologica|November 27, 2025
Complete remission of bronchus-associated lymphoid tissue lymphoma after antibiotic treatment for Tropheryma whippleiTeresa Antonia Kiener, Gregor Schweighofer-Zwink, Gundula Rendl, et al.
BMC Cancer|October 18, 2015
CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancerThomas Melchardt, Clemens Hufnagl, Teresa Magnes, et al.
Cancer Medicine|May 21, 2024
Outcomes of pirtobrutinib for relapsed/refractory mantle cell lymphoma in compassionate use program in EuropeEnver Aydilek, Gerald Wulf, Friedrich Schwarz, et al.
Oncology Letters|January 23, 2020
Evaluation of circulating cell-free DNA as a molecular monitoring tool in patients with metastatic cancerClemens Hufnagl, Michael Leisch, Lukas Weiss, et al.
BMC Cancer|December 24, 2015
Anti-Hu Antibody Associated Paraneoplastic Cerebellar Degeneration in Head and Neck CancerFlorian Huemer, Thomas Melchardt, Wolfgang Tränkenschuh, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 15, 2015
Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPIThomas Melchardt, Katharina Troppan, Lukas Weiss, et al.
Pageof 9